![Q32 Bio Inc](/common/images/company/N_QTTB.png)
Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis PR Newswire WALTHAM, Mass., July 9, 2024 -- Exceeded enrollment target due...
Q32 Bio Joins Russell 3000® Index PR Newswire WALTHAM, Mass., July 1, 2024 WALTHAM, Mass., July 1, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.27 | 25.1035911602 | 28.96 | 42.98 | 27.403 | 105679 | 35.49498253 | CS |
4 | 18.33 | 102.402234637 | 17.9 | 42.98 | 16.86 | 96502 | 26.59537547 | CS |
12 | 10.23 | 39.3461538462 | 26 | 42.98 | 13.59 | 64844 | 24.58220758 | CS |
26 | 19.99 | 123.091133005 | 16.24 | 42.98 | 13.59 | 58703 | 24.61923577 | CS |
52 | 19.99 | 123.091133005 | 16.24 | 42.98 | 13.59 | 58703 | 24.61923577 | CS |
156 | 19.99 | 123.091133005 | 16.24 | 42.98 | 13.59 | 58703 | 24.61923577 | CS |
260 | 19.99 | 123.091133005 | 16.24 | 42.98 | 13.59 | 58703 | 24.61923577 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.